United States Oil & Gas

Parsley Energy Inc (PE)

Track

Track

Parsley Energy Inc. experienced notable insider trading activity throughout 2020. The most recent transactions occurred in August 2020, featuring significant divestments by Bryan Sheffield, Colin Roberts, and Ryan Dalton. Earlier that year, various individuals executed purchase orders. These historical records predate the current three-month window, reflecting past equity movements.
Ticker: PE Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.3
Sheffield Bryan See Remarks Executive Director
Transaction date
Sale
Price
306.22
Quantity 34,862 -39.3%
Value US$2,304,716
1.3
Sheffield Bryan See Remarks Executive Director
Transaction date
Sale
Price
168.20
Quantity 23,330 +10.6%
Value US$2,573,018
1.3
Sheffield Bryan See Remarks Executive Director
Transaction date
Sale
Price
140.32
Quantity 17,196 -9.6%
Value US$4,069,025
Roberts Colin See Remarks Officer
Transaction date
Sale
Price
11.14
Quantity 30,000 -9.7%
Value US$334,200
0.8
Dalton Ryan See Remarks Officer
Transaction date
Sale
Price
11.14
Quantity 60,000 -12.6%
Value US$668,400
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
11.25
Quantity 2,000 +1.4%
Value US$22,500
Brokmeyer Ron Non-Executive Director
Transaction date
Purchase
Price
11.15
Quantity 1,800 +6.2%
Value US$20,070
Windlinger Jerry Non-Executive Director
Transaction date
Purchase
Price
11.32
Quantity 1,618 +4.8%
Value US$18,316
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
12.60
Quantity 1,000 +0.7%
Value US$12,600
Brokmeyer Ron Non-Executive Director
Transaction date
Purchase
Price
12.70
Quantity 1,000 +3.5%
Value US$12,700
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
13.10
Quantity 10,000 +7.6%
Value US$131,000
Roberts Colin See Remarks Officer
Transaction date
Sale
Price
16.36
Quantity 10,000 -3.7%
Value US$163,600
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
15.63
Quantity 316,700 -3.6%
Value US$4,950,021
Brokmeyer Ron Non-Executive Director
Transaction date
Purchase
Price
14.95
Quantity 5,000 +28.2%
Value US$74,750
Windlinger Jerry
Transaction date
Purchase
Price
17.50
Quantity 1,985 +6.3%
Value US$34,738
1.3
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
20.24
Quantity 100,000 -1.1%
Value US$2,024,210
Roberts Colin See Remarks
Transaction date
Sale
Price
20.00
Quantity 3,000 -1.1%
Value US$60,000
Roberts Colin See Remarks
Transaction date
Sale
Price
18.73
Quantity 3,500 -1.3%
Value US$65,558
Hinson Mike See Remarks Officer
Transaction date
Sale
Price
18.43
Quantity 41,727 -9.5%
Value US$769,029
1.3
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
18.25
Quantity 725,000 -7.5%
Value US$13,233,208
Windlinger Jerry Non-Executive Director
Transaction date
Purchase
Price
19.94
Quantity 3,193 +16.1%
Value US$63,668
Brokmeyer Ron Non-Executive Director
Transaction date
Purchase
Price
19.99
Quantity 1,000 +6.0%
Value US$19,990
Brokmeyer Ron Non-Executive Director
Transaction date
Purchase
Price
20.30
Quantity 3,000 +21.9%
Value US$60,900
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
20.00
Quantity 1,000 +0.8%
Value US$20,000
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
21.10
Quantity 5,000 +4.3%
Value US$105,498
Desai Hemang Non-Executive Director
Transaction date
Purchase
Price
27.32
Quantity 1,000 +50.0%
Value US$27,320
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
28.15
Quantity 2,500,000 -21.7%
Value US$70,375,000
Hinson Mike See Remarks Officer
Transaction date
Sale
Price
28.75
Quantity 13,328 -3.2%
Value US$383,180
Hinson Mike See Remarks Officer
Transaction date
Sale
Price
30.24
Quantity 250,000 -37.7%
Value US$7,560,000
Roberts Colin See Remarks Officer
Transaction date
Planned sale
Price
30.21
Quantity 10,000 -4.3%
Value US$302,100
Roberts Colin See Remarks Officer
Transaction date
Planned sale
Price
31.59
Quantity 10,000 -3.9%
Value US$315,900
Hinson Mike See Remarks Officer
Transaction date
Sale
Price
31.95
Quantity 41,681 -9.0%
Value US$1,331,708
Gallagher Matthew See Remarks Executive Director
Transaction date
Sale
Price
31.77
Quantity 142,971 -19.1%
Value US$4,542,189
Dalton Ryan See Remarks Officer
Transaction date
Sale
Price
31.77
Quantity 60,742 -15.4%
Value US$1,929,773
Roberts Colin See Remarks Officer
Transaction date
Planned sale
Price
28.29
Quantity 7,500 -2.9%
Value US$212,175
Windlinger Jerry
Transaction date
Purchase
Price
25.48
Quantity 3,000 +26.5%
Value US$76,440
Smith David Henry
Transaction date
Purchase
Price
25.35
Quantity 2,000 +5.5%
Value US$50,700
Brokmeyer Ron Non-Executive Director
Transaction date
Purchase
Price
25.66
Quantity 2,000 +17.1%
Value US$51,320
Roberts Colin See Remarks Officer
Transaction date
Sale
Price
26.14
Quantity 10,000 -3.7%
Value US$261,400
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
25.99
Quantity 10,000 +9.8%
Value US$259,900
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Purchase
Price
26.34
Quantity 189,500 +1.7%
Value US$4,991,430
Roberts Colin See Remarks
Transaction date
Sale
Price
30.00
Quantity 3,400 -1.5%
Value US$102,000
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
31.65
Quantity 1,600 +1.7%
Value US$50,632
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
31.65
Quantity 1,900 +2.0%
Value US$60,128
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
31.45
Quantity 837,500 -6.9%
Value US$26,339,375
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Sale
Price
31.40
Quantity 850,000 -6.6%
Value US$26,690,000
Dalton Ryan See Remarks Officer
Transaction date
Sale
Price
32.56
Quantity 30,000 -8.3%
Value US$976,800
Roberts Colin See Remarks Officer
Transaction date
Planned sale
Price
29.56
Quantity 3,000 -1.3%
Value US$88,680
Roberts Colin See Remarks
Transaction date
Planned sale
Price
32.10
Quantity 15,598 -6.2%
Value US$500,696
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
30.94
Quantity 3,500 +3.9%
Value US$108,290
Gallagher Matthew See remarks
Transaction date
Purchase
Price
30.44
Quantity 1,270 +0.2%
Value US$38,659
Gallagher Matthew See remarks
Transaction date
Purchase
Price
30.19
Quantity 31,715 +5.0%
Value US$957,476
Windlinger Jerry
Transaction date
Purchase
Price
30.35
Quantity 3,000 +112.5%
Value US$91,050
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
36.05
Quantity 25,000 -5.6%
Value US$901,250
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
36.18
Quantity 25,000 -5.3%
Value US$904,500
Dalton Ryan See Remarks Officer
Transaction date
Sale
Price
34.90
Quantity 12,700 -5.1%
Value US$443,230
Roberts Colin Vice President-General Counsel Officer
Transaction date
Sale
Price
34.92
Quantity 5,000 -2.1%
Value US$174,600
ALAMEDDINE A R Non-Executive Director
Transaction date
Purchase
Price
34.75
Quantity 8,000 +9.8%
Value US$278,000
Dalton Ryan See Remarks Officer
Transaction date
Sale
Price
35.11
Quantity 7,300 -2.9%
Value US$256,303
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Planned sale
Price
34.66
Quantity 28,676 -0.2%
Value US$993,910
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Planned sale
Price
35.38
Quantity 33,824 -0.3%
Value US$1,196,693
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Planned sale
Price
34.73
Quantity 113,806 -0.9%
Value US$3,952,482
Sheffield Bryan See Remarks Executive Director Large shareholder
Transaction date
Planned sale
Price
34.95
Quantity 136,194 -1.0%
Value US$4,759,980
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
34.05
Quantity 25,000 -5.0%
Value US$851,250
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
36.04
Quantity 25,000 -4.8%
Value US$901,000
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
34.90
Quantity 14,500 -2.7%
Value US$506,050
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
35.44
Quantity 10,500 -1.9%
Value US$372,120
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
33.65
Quantity 25,000 -4.4%
Value US$841,250
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
34.39
Quantity 25,000 -4.2%
Value US$859,750
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
33.62
Quantity 25,000 -4.0%
Value US$840,500
Gallagher Matthew See Remarks Officer
Transaction date
Sale
Price
33.83
Quantity 9,300 -1.5%
Value US$314,619
Gallagher Matthew See Remarks Officer
Transaction date
Sale
Price
33.89
Quantity 30,300 -4.8%
Value US$1,026,867
Gallagher Matthew See Remarks Officer
Transaction date
Sale
Price
33.74
Quantity 5,400 -0.8%
Value US$182,196
Hinson Mike See Remarks Officer
Transaction date
Planned sale
Price
32.87
Quantity 25,000 -3.9%
Value US$821,750
Gallagher Matthew See Remarks Officer
Transaction date
Sale
Price
32.64
Quantity 45,000 -6.5%
Value US$1,468,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-08-20 2020-08-20 S Sale
1.3
Sheffield Bryan

See Remarks

Executive Director
34,862 -39.3%
306.22
US$2,304,716 		34,862 -39.3% 306.22 US$2,304,716
2020-08-20 2020-08-19 S Sale
1.3
Sheffield Bryan

See Remarks

Executive Director
23,330 +10.6%
168.20
US$2,573,018 		23,330 +10.6% 168.20 US$2,573,018
2020-08-20 2020-08-18 S Sale
1.3
Sheffield Bryan

See Remarks

Executive Director
17,196 -9.6%
140.32
US$4,069,025 		17,196 -9.6% 140.32 US$4,069,025
2020-08-07 2020-08-07 S Sale
Roberts Colin

See Remarks

Officer
30,000 -9.7%
11.14
US$334,200 		30,000 -9.7% 11.14 US$334,200
2020-08-07 2020-08-07 S Sale
0.8
Dalton Ryan

See Remarks

Officer
60,000 -12.6%
11.14
US$668,400 		60,000 -12.6% 11.14 US$668,400
2020-03-09 2020-03-06 B Purchase
ALAMEDDINE A R
Non-Executive Director
2,000 +1.4%
11.25
US$22,500 		2,000 +1.4% 11.25 US$22,500
2020-03-09 2020-03-06 B Purchase
Brokmeyer Ron
Non-Executive Director
1,800 +6.2%
11.15
US$20,070 		1,800 +6.2% 11.15 US$20,070
2020-03-09 2020-03-06 B Purchase
Windlinger Jerry
Non-Executive Director
1,618 +4.8%
11.32
US$18,316 		1,618 +4.8% 11.32 US$18,316
2020-03-09 2020-03-05 B Purchase
ALAMEDDINE A R
Non-Executive Director
1,000 +0.7%
12.60
US$12,600 		1,000 +0.7% 12.60 US$12,600
2020-03-04 2020-03-03 B Purchase
Brokmeyer Ron
Non-Executive Director
1,000 +3.5%
12.70
US$12,700 		1,000 +3.5% 12.70 US$12,700
2020-02-28 2020-02-27 B Purchase
ALAMEDDINE A R
Non-Executive Director
10,000 +7.6%
13.10
US$131,000 		10,000 +7.6% 13.10 US$131,000
2019-12-06 2019-12-06 S Sale Roberts Colin

See Remarks

Officer
10,000 -3.7%
16.36
US$163,600 		10,000 -3.7% 16.36 US$163,600
2019-12-06 2019-12-05 S Sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
316,700 -3.6%
15.63
US$4,950,021 		316,700 -3.6% 15.63 US$4,950,021
2019-12-02 2019-11-29 B Purchase Brokmeyer Ron Non-Executive Director
5,000 +28.2%
14.95
US$74,750 		5,000 +28.2% 14.95 US$74,750
2019-06-06 2019-06-05 B Purchase
Windlinger Jerry
1,985 +6.3%
17.50
US$34,738 		1,985 +6.3% 17.50 US$34,738
2019-05-22 2019-05-20 S Sale
1.3
Sheffield Bryan

See Remarks

Executive Director Large shareholder
100,000 -1.1%
20.24
US$2,024,210 		100,000 -1.1% 20.24 US$2,024,210
2019-04-12 2019-04-12 S Sale
Roberts Colin

See Remarks
3,000 -1.1%
20.00
US$60,000 		3,000 -1.1% 20.00 US$60,000
2019-03-06 2019-03-05 S Sale
Roberts Colin

See Remarks
3,500 -1.3%
18.73
US$65,558 		3,500 -1.3% 18.73 US$65,558
2019-03-01 2019-03-01 S Sale
Hinson Mike

See Remarks

Officer
41,727 -9.5%
18.43
US$769,029 		41,727 -9.5% 18.43 US$769,029
2019-03-01 2019-02-28 S Sale
1.3
Sheffield Bryan

See Remarks

Executive Director Large shareholder
725,000 -7.5%
18.25
US$13,233,208 		725,000 -7.5% 18.25 US$13,233,208
2018-12-06 2018-12-04 B Purchase Windlinger Jerry Non-Executive Director
3,193 +16.1%
19.94
US$63,668 		3,193 +16.1% 19.94 US$63,668
2018-12-04 2018-12-04 B Purchase Brokmeyer Ron Non-Executive Director
1,000 +6.0%
19.99
US$19,990 		1,000 +6.0% 19.99 US$19,990
2018-12-03 2018-11-30 B Purchase Brokmeyer Ron Non-Executive Director
3,000 +21.9%
20.30
US$60,900 		3,000 +21.9% 20.30 US$60,900
2018-12-03 2018-11-30 B Purchase ALAMEDDINE A R Non-Executive Director
1,000 +0.8%
20.00
US$20,000 		1,000 +0.8% 20.00 US$20,000
2018-11-27 2018-11-27 B Purchase ALAMEDDINE A R Non-Executive Director
5,000 +4.3%
21.10
US$105,498 		5,000 +4.3% 21.10 US$105,498
2018-09-05 2018-09-04 B Purchase Desai Hemang Non-Executive Director
1,000 +50.0%
27.32
US$27,320 		1,000 +50.0% 27.32 US$27,320
2018-08-30 2018-08-28 S Sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
2,500,000 -21.7%
28.15
US$70,375,000 		2,500,000 -21.7% 28.15 US$70,375,000
2018-08-24 2018-08-24 S Sale Hinson Mike

See Remarks

Officer
13,328 -3.2%
28.75
US$383,180 		13,328 -3.2% 28.75 US$383,180
2018-08-10 2018-08-10 S Sale Hinson Mike

See Remarks

Officer
250,000 -37.7%
30.24
US$7,560,000 		250,000 -37.7% 30.24 US$7,560,000
2018-06-29 2018-06-27 PlS Planned sale Roberts Colin

See Remarks

Officer
10,000 -4.3%
30.21
US$302,100 		10,000 -4.3% 30.21 US$302,100
2018-05-17 2018-05-15 PlS Planned sale Roberts Colin

See Remarks

Officer
10,000 -3.9%
31.59
US$315,900 		10,000 -3.9% 31.59 US$315,900
2018-05-10 2018-05-08 S Sale Hinson Mike

See Remarks

Officer
41,681 -9.0%
31.95
US$1,331,708 		41,681 -9.0% 31.95 US$1,331,708
2018-05-10 2018-05-08 S Sale Gallagher Matthew

See Remarks

Executive Director
142,971 -19.1%
31.77
US$4,542,189 		142,971 -19.1% 31.77 US$4,542,189
2018-05-10 2018-05-08 S Sale Dalton Ryan

See Remarks

Officer
60,742 -15.4%
31.77
US$1,929,773 		60,742 -15.4% 31.77 US$1,929,773
2018-04-04 2018-04-02 PlS Planned sale Roberts Colin

See Remarks

Officer
7,500 -2.9%
28.29
US$212,175 		7,500 -2.9% 28.29 US$212,175
2018-03-02 2018-03-01 B Purchase Windlinger Jerry
3,000 +26.5%
25.48
US$76,440 		3,000 +26.5% 25.48 US$76,440
2018-03-01 2018-03-01 B Purchase Smith David Henry
2,000 +5.5%
25.35
US$50,700 		2,000 +5.5% 25.35 US$50,700
2018-02-28 2018-02-28 B Purchase Brokmeyer Ron Non-Executive Director
2,000 +17.1%
25.66
US$51,320 		2,000 +17.1% 25.66 US$51,320
2018-02-28 2018-02-27 S Sale Roberts Colin

See Remarks

Officer
10,000 -3.7%
26.14
US$261,400 		10,000 -3.7% 26.14 US$261,400
2018-02-28 2018-02-27 B Purchase ALAMEDDINE A R Non-Executive Director
10,000 +9.8%
25.99
US$259,900 		10,000 +9.8% 25.99 US$259,900
2018-02-26 2018-02-26 B Purchase Sheffield Bryan

See Remarks

Executive Director Large shareholder
189,500 +1.7%
26.34
US$4,991,430 		189,500 +1.7% 26.34 US$4,991,430
2017-06-02 2017-06-01 S Sale Roberts Colin

See Remarks
3,400 -1.5%
30.00
US$102,000 		3,400 -1.5% 30.00 US$102,000
2017-05-19 2017-05-17 B Purchase ALAMEDDINE A R Non-Executive Director
1,600 +1.7%
31.65
US$50,632 		1,600 +1.7% 31.65 US$50,632
2017-05-19 2017-05-17 B Purchase ALAMEDDINE A R Non-Executive Director
1,900 +2.0%
31.65
US$60,128 		1,900 +2.0% 31.65 US$60,128
2017-05-12 2017-05-11 S Sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
837,500 -6.9%
31.45
US$26,339,375 		837,500 -6.9% 31.45 US$26,339,375
2017-05-12 2017-05-10 S Sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
850,000 -6.6%
31.40
US$26,690,000 		850,000 -6.6% 31.40 US$26,690,000
2017-05-12 2017-05-10 S Sale Dalton Ryan

See Remarks

Officer
30,000 -8.3%
32.56
US$976,800 		30,000 -8.3% 32.56 US$976,800
2017-05-02 2017-05-01 PlS Planned sale Roberts Colin

See Remarks

Officer
3,000 -1.3%
29.56
US$88,680 		3,000 -1.3% 29.56 US$88,680
2017-03-31 2017-03-31 PlS Planned sale Roberts Colin

See Remarks
15,598 -6.2%
32.10
US$500,696 		15,598 -6.2% 32.10 US$500,696
2017-03-02 2017-03-01 B Purchase ALAMEDDINE A R Non-Executive Director
3,500 +3.9%
30.94
US$108,290 		3,500 +3.9% 30.94 US$108,290
2017-03-02 2017-02-28 B Purchase Gallagher Matthew

See remarks
1,270 +0.2%
30.44
US$38,659 		1,270 +0.2% 30.44 US$38,659
2017-03-02 2017-02-28 B Purchase Gallagher Matthew

See remarks
31,715 +5.0%
30.19
US$957,476 		31,715 +5.0% 30.19 US$957,476
2017-03-02 2017-02-28 B Purchase Windlinger Jerry
3,000 +112.5%
30.35
US$91,050 		3,000 +112.5% 30.35 US$91,050
2016-12-09 2016-12-07 PlS Planned sale Hinson Mike

See Remarks

Officer
25,000 -5.6%
36.05
US$901,250 		25,000 -5.6% 36.05 US$901,250
2016-11-23 2016-11-21 PlS Planned sale
Hinson Mike

See Remarks

Officer
25,000 -5.3%
36.18
US$904,500 		25,000 -5.3% 36.18 US$904,500
2016-11-18 2016-11-18 S Sale Dalton Ryan

See Remarks

Officer
12,700 -5.1%
34.90
US$443,230 		12,700 -5.1% 34.90 US$443,230
2016-11-18 2016-11-18 S Sale Roberts Colin

Vice President-General Counsel

Officer
5,000 -2.1%
34.92
US$174,600 		5,000 -2.1% 34.92 US$174,600
2016-11-18 2016-11-17 B Purchase ALAMEDDINE A R Non-Executive Director
8,000 +9.8%
34.75
US$278,000 		8,000 +9.8% 34.75 US$278,000
2016-11-18 2016-11-17 S Sale Dalton Ryan

See Remarks

Officer
7,300 -2.9%
35.11
US$256,303 		7,300 -2.9% 35.11 US$256,303
2016-11-17 2016-11-17 PlS Planned sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
28,676 -0.2%
34.66
US$993,910 		28,676 -0.2% 34.66 US$993,910
2016-11-17 2016-11-17 PlS Planned sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
33,824 -0.3%
35.38
US$1,196,693 		33,824 -0.3% 35.38 US$1,196,693
2016-11-17 2016-11-16 PlS Planned sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
113,806 -0.9%
34.73
US$3,952,482 		113,806 -0.9% 34.73 US$3,952,482
2016-11-17 2016-11-15 PlS Planned sale Sheffield Bryan

See Remarks

Executive Director Large shareholder
136,194 -1.0%
34.95
US$4,759,980 		136,194 -1.0% 34.95 US$4,759,980
2016-11-09 2016-11-07 PlS Planned sale Hinson Mike

See Remarks

Officer
25,000 -5.0%
34.05
US$851,250 		25,000 -5.0% 34.05 US$851,250
2016-10-24 2016-10-21 PlS Planned sale
Hinson Mike

See Remarks

Officer
25,000 -4.8%
36.04
US$901,000 		25,000 -4.8% 36.04 US$901,000
2016-10-07 2016-10-05 PlS Planned sale Hinson Mike

See Remarks

Officer
14,500 -2.7%
34.90
US$506,050 		14,500 -2.7% 34.90 US$506,050
2016-10-07 2016-10-05 PlS Planned sale
Hinson Mike

See Remarks

Officer
10,500 -1.9%
35.44
US$372,120 		10,500 -1.9% 35.44 US$372,120
2016-09-14 2016-09-12 PlS Planned sale
Hinson Mike

See Remarks

Officer
25,000 -4.4%
33.65
US$841,250 		25,000 -4.4% 33.65 US$841,250
2016-09-08 2016-09-06 PlS Planned sale Hinson Mike

See Remarks

Officer
25,000 -4.2%
34.39
US$859,750 		25,000 -4.2% 34.39 US$859,750
2016-08-26 2016-08-24 PlS Planned sale Hinson Mike

See Remarks

Officer
25,000 -4.0%
33.62
US$840,500 		25,000 -4.0% 33.62 US$840,500
2016-08-24 2016-08-24 S Sale Gallagher Matthew

See Remarks

Officer
9,300 -1.5%
33.83
US$314,619 		9,300 -1.5% 33.83 US$314,619
2016-08-24 2016-08-23 S Sale Gallagher Matthew

See Remarks

Officer
30,300 -4.8%
33.89
US$1,026,867 		30,300 -4.8% 33.89 US$1,026,867
2016-08-24 2016-08-22 S Sale Gallagher Matthew

See Remarks

Officer
5,400 -0.8%
33.74
US$182,196 		5,400 -0.8% 33.74 US$182,196
2016-08-12 2016-08-10 PlS Planned sale Hinson Mike

See Remarks

Officer
25,000 -3.9%
32.87
US$821,750 		25,000 -3.9% 32.87 US$821,750
2016-08-11 2016-08-09 S Sale Gallagher Matthew

See Remarks

Officer
45,000 -6.5%
32.64
US$1,468,800 		45,000 -6.5% 32.64 US$1,468,800
Explore more

More insider trading research around Parsley Energy Inc

More insider trades in United States
Similar Energy companies with insider activity
More Energy - Fossil Fuels companies with insider activity
More Oil & Gas companies with insider activity
Insider trading in North America